Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2178352

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1

Basic Information

ChEMBL ID CHEMBL2178352
Phase Preclinical
Structure Type MOL
InChI Key QPOURHROVVCOHC-UHFFFAOYSA-N
30
Targets
52
Activities
2
Assay Types
5
PK Parameters
20
Publications
0
Known Names

Molecular Properties

468.6
MW (Da)
5.18
ALogP
8
HBA
2
HBD
74.1
PSA (Ų)
0.40
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C27H32N8
MW 468.61
Aromatic Rings 4
Heavy Atoms 35
NP-Likeness -1.27

Activity Summary

IC50 43 meas. best 9.66
Kd 9 meas. best 9.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
PC-9
CHEMBL614102
IC50 9.66 9.66 0.2 1
Unchecked
CHEMBL612545
Kd 9.4 9.3333 0.4 3
Epidermal growth factor receptor
CHEMBL203
Kd 9.3 9.1517 0.5 6
HCC827
CHEMBL4296422
IC50 9.09 8.5233 0.8 3
Epidermal growth factor receptor
CHEMBL203
IC50 9.0 7.6 1.0 6
Vascular endothelial growth factor receptor 2
CHEMBL279
IC50 8.15 7.925 7.0 2
FaDu
CHEMBL612250
IC50 7.82 7.82 15.0 1
Receptor tyrosine-protein kinase erbB-4
CHEMBL3009
IC50 7.52 7.52 30.0 1
NCI-H292
CHEMBL614733
IC50 7.35 7.35 45.0 1
Receptor tyrosine-protein kinase erbB-2
CHEMBL1824
IC50 7.22 7.22 60.0 1
Calu-3
CHEMBL614534
IC50 6.92 6.92 120.0 1
A-431
CHEMBL614069
IC50 6.92 6.855 120.0 2
Mitogen-activated protein kinase 14
CHEMBL260
IC50 6.64 6.64 230.0 1
Proto-oncogene tyrosine-protein kinase Src
CHEMBL267
IC50 6.54 6.54 290.0 1
NCI-H1975
CHEMBL614348
IC50 6.47 6.4267 342.0 3
Mast/stem cell growth factor receptor Kit
CHEMBL1936
IC50 6.27 6.27 540.0 1
Lysine--tRNA ligase
CHEMBL5575
IC50 6.14 6.14 720.0 1
Unchecked
CHEMBL612545
IC50 5.96 5.495 1100.0 2
Tyrosine-protein kinase JAK2
CHEMBL2971
IC50 5.92 5.92 1200.0 1
Mitogen-activated protein kinase 9
CHEMBL4179
IC50 5.82 5.82 1500.0 1
ALK tyrosine kinase receptor
CHEMBL4247
IC50 5.64 5.64 2300.0 1
Tyrosine-protein kinase JAK3
CHEMBL2148
IC50 5.58 5.58 2600.0 1
HCT-116
CHEMBL394
IC50 5.52 5.52 3000.0 1
MAP kinase-interacting serine/threonine-protein kinase 2
CHEMBL4204
IC50 5.5 5.5 3200.0 1
Tyrosine-protein kinase JAK1
CHEMBL2835
IC50 5.48 5.48 3300.0 1
Protein kinase C theta type
CHEMBL3920
IC50 5.44 5.44 3600.0 1
MDA-MB-231
CHEMBL400
IC50 5.3 5.3 5000.0 1
Serine/threonine-protein kinase N1
CHEMBL3384
IC50 5.21 5.21 6100.0 1
Hepatocyte growth factor receptor
CHEMBL3717
IC50 5.19 5.19 6400.0 1
MAP kinase-interacting serine/threonine-protein kinase 1
CHEMBL4718
IC50 5.17 5.17 6700.0 1
Non-receptor tyrosine-protein kinase TYK2
CHEMBL3553
IC50 5.17 5.17 6700.0 1
Protein kinase C alpha type
CHEMBL299
IC50 5.17 5.17 6700.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 2140.0 ng.hr.mL-1 Rattus norvegicus
CL 162.0 mL.min-1.kg-1 Rattus norvegicus
Cmax 490.81 nM Rattus norvegicus
T1/2 4.86 hr Rattus norvegicus
Tmax 1.0 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
PC-9 IC50 = 0.22 nM 9.66 Cytotoxicity against human PC9 cells incubated for 72 hrs by MTT assay 23116168
Unchecked Kd = 0.4 nM 9.4 Binding affinity to wild type EGFR 747-E749del, A750P mutant by KINOMEscan kinas... 23116168
Epidermal growth factor receptor Kd = 0.5 nM 9.3 Binding affinity to wild type EGFR G719S mutant by KINOMEscan kinase binding ass... 23116168
Unchecked Kd = 0.5 nM 9.3 Binding affinity to wild type EGFR L747-S752del, Sins mutant by KINOMEscan kinas... 23116168
Unchecked Kd = 0.5 nM 9.3 Binding affinity to wild type EGFR E646-A750del mutant by KINOMEscan kinase bind... 23116168
Epidermal growth factor receptor Kd = 0.6 nM 9.22 Binding affinity to wild type EGFR by KINOMEscan kinase binding assay 23116168
Epidermal growth factor receptor Kd = 0.6 nM 9.22 Binding affinity to wild type EGFR L858R mutant by KINOMEscan kinase binding ass... 23116168
Epidermal growth factor receptor Kd = 0.6 nM 9.22 Binding affinity to wild type EGFR L861Q mutant by KINOMEscan kinase binding ass... 23116168
Epidermal growth factor receptor Kd = 0.7 nM 9.15 Binding affinity to wild type EGFR G719C mutant by KINOMEscan kinase binding ass... 23116168
HCC827 IC50 = 0.82 nM 9.09 Antiproliferative activity against human HCC827 cells expressing EGFR del19 muta... 32883633
HCC827 IC50 = 0.93 nM 9.03 Antiproliferative activity against human HCC827 cells expressing EGFR deletion19... 35254067
Epidermal growth factor receptor IC50 = 1.0 nM 9.0 Inhibition Assay: The object of this assay was to test the inventive compounds f... -
Epidermal growth factor receptor IC50 = 1.0 nM 9.0 Inhibition Assay: The object of this assay was to test the inventive compounds f... -
Epidermal growth factor receptor Kd = 1.6 nM 8.8 Binding affinity to wild type EGFR L858R and T790M mutant by KINOMEscan kinase b... 23116168
Epidermal growth factor receptor IC50 = 4.0 nM 8.4 Inhibition of human recombinant EGFR by radiometric kinase assay 23116168
Vascular endothelial growth factor receptor 2 IC50 = 7.0 nM 8.15 Inhibition Assay: The object of this assay was to test the inventive compounds f... -
FaDu IC50 = 15.0 nM 7.82 Cytotoxicity against human FADU cells incubated for 72 hrs by MTT assay 23116168
Vascular endothelial growth factor receptor 2 IC50 = 20.0 nM 7.7 Inhibition of human recombinant VEGFR2 by radiometric kinase assay 23116168
Receptor tyrosine-protein kinase erbB-4 IC50 = 30.0 nM 7.52 Inhibition of human recombinant ERBB4 by radiometric kinase assay 23116168
HCC827 IC50 = 35.9 nM 7.45 Antiproliferative activity against human HCC827 cells after 72 hrs by MTT assay 29576272

Literature References

PubMed DOI Target Context # Activities
23116168 10.1021/jm301365e Epidermal growth factor receptor 16
23116168 10.1021/jm301365e Unchecked 7
23116168 10.1021/jm301365e Rattus norvegicus 6
23116168 10.1021/jm301365e NON-PROTEIN TARGET 6
23116168 10.1021/jm301365e NCI-H1975 5
23116168 10.1021/jm301365e Mus musculus 3
29576272 10.1016/j.bmc.2018.03.025 HCC827 2
23116168 10.1021/jm301365e FaDu 1
23116168 10.1021/jm301365e A-431 1
23116168 10.1021/jm301365e NCI-H292 1
23116168 10.1021/jm301365e Calu-3 1
23116168 10.1021/jm301365e PC-9 1
23116168 10.1021/jm301365e Mitogen-activated protein kinase 12 1
23116168 10.1021/jm301365e Mitogen-activated protein kinase 14 1
23116168 10.1021/jm301365e Serine/threonine-protein kinase WNK1 1
23116168 10.1021/jm301365e Vascular endothelial growth factor receptor 2 1
23116168 10.1021/jm301365e Non-receptor tyrosine-protein kinase TYK2 1
23116168 10.1021/jm301365e MDA-MB-231 1
23116168 10.1021/jm301365e Rho-associated protein kinase 2 1
35254067 10.1021/acs.jmedchem.1c01827 A-431 1

Data from ChEMBL 36 via Core Engine